Qnovia website screenshot

Qnovia

Qnovia, Inc. is a clinical-stage pharmaceutical and drug-device company developing inhaled therapeutics built on its proprietary RespiRx aseptically pre-filled, portable vibrating-mesh nebulizer platform. Its lead asset, the RespiRx Nicotine Inhaler (QN-01), is a prescription smoking-cessation therapy that cleared FDA IND review and has dosed patients in a U.S. Phase 1 study; a cognitive behavioral therapy (CBT) program is advancing toward a second IND. The device is Bluetooth Low Energy connected and pairs with Neblit AI, a cloud-connected companion app and machine-learning platform that tracks dose events and delivers behavioral interventions, which the company positions as a digital therapeutic layer over the pharmacotherapy. Founded in 2018 as Respira Technologies and rebranded to Qnovia in 2022, the company is led by founder and CEO Mario Danek, operates R&D and manufacturing in Newport Beach/Irvine, California and an R&D facility in Richmond, Virginia, and has raised roughly $50 million to date. Qnovia publishes no public API, developer portal, SDK, or machine-readable contract; its corporate site is a client-rendered single-page application whose only HTTP API is a private backend serving its own contact, careers and investor-portal forms.

Qnovia is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Medical Devices, Drug Delivery, and Digital Health.

Qnovia’s developer surface includes product news, support, and 16 more developer resources.

4.1/100 minimal ▬ flat Agent 3/100 human only saas Full breakdown ↓
scored 2026-09-02 · rubric v0.18.0
0 APIs
CompanyPharmaceuticalsMedical DevicesDrug DeliveryDigital HealthDigital TherapeuticsRespiratorySmoking CessationConnected DevicesClinical TrialsArtificial IntelligenceHealth

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-02 · rubric v0.18.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/qnovia: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Pricing Plans 1

Published pricing tiers and plan structures.

Qnovia Plans Pricing

0 plans

PLANS

Rate Limits 1

Documented rate limits and quota policies.

Qnovia Rate Limits

0 limits

RATE LIMITS

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Qnovia Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Build 1

SDKs, sample code, and the tooling you integrate with

Access & Security 1

Authentication, authorization, and security posture

Operate 2

Status, limits, changes, and where to get help

Commercial 3

Pricing, plans, and the legal terms of use

Company 5

The organization behind the API

Other 5

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: qnovia
name: Qnovia
description: Qnovia, Inc. is a clinical-stage pharmaceutical and drug-device company developing inhaled therapeutics built
  on its proprietary RespiRx aseptically pre-filled, portable vibrating-mesh nebulizer platform. Its lead asset, the RespiRx
  Nicotine Inhaler (QN-01), is a prescription smoking-cessation therapy that cleared FDA IND review and has dosed patients
  in a U.S. Phase 1 study; a cognitive behavioral therapy (CBT) program is advancing toward a second IND. The device is Bluetooth
  Low Energy connected and pairs with Neblit AI, a cloud-connected companion app and machine-learning platform that tracks
  dose events and delivers behavioral interventions, which the company positions as a digital therapeutic layer over the pharmacotherapy.
  Founded in 2018 as Respira Technologies and rebranded to Qnovia in 2022, the company is led by founder and CEO Mario Danek,
  operates R&D and manufacturing in Newport Beach/Irvine, California and an R&D facility in Richmond, Virginia, and has raised
  roughly $50 million to date. Qnovia publishes no public API, developer portal, SDK, or machine-readable contract; its corporate
  site is a client-rendered single-page application whose only HTTP API is a private backend serving its own contact, careers
  and investor-portal forms.
url: https://raw.githubusercontent.com/api-evangelist/qnovia/refs/heads/main/apis.yml
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - rate-limits
  - security
  generated: '2026-09-02'
  method: derived
image: https://qnovia.com/favicon.png
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Pharmaceuticals
- Medical Devices
- Drug Delivery
- Digital Health
- Digital Therapeutics
- Respiratory
- Smoking Cessation
- Connected Devices
- Clinical Trials
- Artificial Intelligence
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://qnovia.com/
- type: About
  url: https://qnovia.com/about/story
- type: Product
  url: https://qnovia.com/product
- type: Technology
  url: https://qnovia.com/technology
- type: Pipeline
  url: https://qnovia.com/pipeline
- type: Team
  url: https://qnovia.com/team
- type: News
  url: https://qnovia.com/news
- type: Careers
  url: https://qnovia.com/careers
- type: Support
  url: https://qnovia.com/contact
- type: Investors
  url: https://qnovia.com/investors
- type: TermsOfService
  url: https://qnovia.com/terms
- type: PrivacyPolicy
  url: https://qnovia.com/privacy
- type: SecondaryMarket
  url: https://forgeglobal.com/qnovia_stock/
- type: DomainSecurity
  url: security/qnovia-domain-security.yml
- type: LLMsTxt
  url: llms/qnovia-llms.txt
- type: Packages
  url: packages/qnovia-packages.yml
- type: Plans
  url: plans/qnovia-plans-pricing.yml
- type: RateLimits
  url: rate-limits/qnovia-rate-limits.yml
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 6
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: 'Qnovia is a clinical-stage drug-device company that does write software — BLE device firmware and the cloud-connected
    Neblit AI companion app — but ships none of it to third parties: the qnovia.com route table extracted from its own JavaScript
    bundle has no developer, API or docs route, and the only HTTP API on the host is the private /api/ backend behind its
    contact and investor-portal forms, which answered 401 "Not authenticated".'
  evidence:
  - url: https://qnovia.com/api/investors/me
    status: 401
  - url: https://qnovia.com/openapi.json
    status: 200
  - url: https://qnovia.com/.well-known/agent-card.json
    status: 200
  - url: https://api.github.com/orgs/qnovia
    status: 404
  checked: '2026-08-26'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/qnovia"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/qnovia/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/qnovia/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.